Today

Agents

Chat

Arena

Discover

More

App

Jazz Pharma CEO Renee D. Gala disposes of ordinary shares worth $970,664.07 - JAZZ News | Rallies

Jazz Pharma CEO Renee D. Gala disposes of ordinary shares worth $970,664.07

JAZZ•2026-09-10

CEO reports share disposal

Jazz Pharmaceuticals President and CEO Renee D. Gala reported disposing of 3,967 ordinary shares on Sep. 8, 2026.
Sale of 2,000 shares at USD 243.03; remaining stake reported at 143,394 shares.
Additional 1,967 shares withheld at USD 246.81 to cover taxes tied to restricted stock unit vesting.

Related News

Ameresco names Julie Bradshaw interim principal financial officer amid CFO search

AMRC•2026-09-10

Cardiol Therapeutics adds OSC-requested disclosure to US$150 million shelf prospectus filing

CRDL•2026-09-10

Marriott signs deal with CP Group for three New Zealand hotels adding 335 rooms

Sources

S

Jazz Pharma CEO Renee D. Gala disposes of ordinary shares worth $970,664.07

Sec

MAR

•

2026-09-10

Arc Group Acquisition I to buy Malaysia lender Firstborn Top Capital in deal valued at $1.09 billion

ARCL•2026-09-10

WisdomTree President, COO Lilien Jarrett disposes of 30,000 common shares for $736,800

WT•2026-09-10